IDEAYA Biosciences (IDYA) Non-Current Assets (2018 - 2026)

IDEAYA Biosciences has reported Non-Current Assets for 9 years, with the latest figure at $334.2 million in Q1 2026.

• Quarterly Non-Current Assets fell 14.9% year-over-year to $334.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 8.58% YoY) and the FY2025 annual result came in at $442.6 million, up 1.89% from the prior year.
• Non-Current Assets declined to $334.2 million in Q1 2026 per IDYA's latest filing, from $442.6 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $442.6 million in Q4 2025 and troughed at $17.5 million in Q3 2022.
• A 5-year average of $210.6 million and a median of $252.2 million in 2024 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets plunged 86.61% in 2022, then soared 1113.07% in 2024.
• Over 5 years, Non-Current Assets stood at $17.5 million in 2022, then soared by 566.19% to $116.7 million in 2023, then surged by 272.27% to $434.4 million in 2024, then climbed by 1.89% to $442.6 million in 2025, then declined by 24.48% to $334.2 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $334.2 million, $442.6 million, and $382.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.